Search Results - "Kohman, Leslie J."

Lobar or Sublobar Resection for Peripheral Stage IA Non–Small-Cell Lung Cancer by Altorki, Nasser, Wang, Xiaofei, Kozono, David, Watt, Colleen, Landrenau, Rodney, Wigle, Dennis, Port, Jeffrey, Jones, David R., Conti, Massimo, Ashrafi, Ahmad S., Liberman, Moishe, Yasufuku, Kazuhiro, Yang, Stephen, Mitchell, John D., Pass, Harvey, Keenan, Robert, Bauer, Thomas, Miller, Daniel, Kohman, Leslie J., Stinchcombe, Thomas E., Vokes, Everett

“…In a randomized trial, sublobar resection was noninferior to lobectomy for disease-free survival among patients with peripheral clinical stage T1aN0 (≤2 cm)…”
Get full text

Biopsy first: Lessons learned from Cancer and Leukemia Group B (CALGB) 140503 by Kohman, Leslie J., MD, Gu, Lin, MS, Altorki, Nasser, MD, Scalzetti, Ernest, MD, Veit, Linda J., MPH, Wallen, Jason M., MD, Wang, Xiaofei, PhD

“…Abstract Objective Cancer and Leukemia Group B 140503 is an ongoing, multicenter randomized trial assessing whether sublobar resection is equivalent to…”
Get full text

VATS Lobectomy Has Better Perioperative Outcomes Than Open Lobectomy: CALGB 31001, an Ancillary Analysis of CALGB 140202 (Alliance) by Nwogu, Chukwumere E., MD, PhD, D’Cunha, Jonathan, MD, PhD, Pang, Herbert, PhD, Gu, Lin, MS, Wang, Xiaofei, PhD, Richards, William G., PhD, Veit, Linda J., MPH, Demmy, Todd L., MD, Sugarbaker, David J., MD, Kohman, Leslie J., MD, Swanson, Scott J., MD

“…Background The short-term superiority of video-assisted thoracoscopic surgery lobectomy compared with open lobectomy for early-stage lung cancer has been…”
Get full text

Effect of Number of Lymph Nodes Sampled on Outcome in Patients With Stage I Non–Small-Cell Lung Cancer by GAJRA, Ajeet, NEWMAN, Nancy, GAMBLE, Gary P, KOHMAN, Leslie J, GRAZIANO, Stephen L

“…We postulate that surgical sampling and pathologic evaluation of lymph nodes of surgical specimens from patients with stage I non-small-cell lung cancer…”
Get full text

Prospective phase II trial of preresection thoracoscopic mediastinal restaging after neoadjuvant therapy for IIIA (N2) non–small cell lung cancer: Results of CALGB Protocol 39803 by Jaklitsch, Michael T., MD, Gu, Lin, MS, Demmy, Todd, MD, Harpole, David H., MD, D'Amico, Thomas A., MD, McKenna, Robert J., MD, Krasna, Mark J., MD, Kohman, Leslie J., MD, Swanson, Scott J., MD, DeCamp, Malcolm M., MD, Wang, Xiaofei, PhD, Barry, Susan, BS, Sugarbaker, David J., MD

“…Objective Accurate pathologic restaging of N2 stations after neoadjuvant therapy in stage IIIA (N2) non–small cell lung cancer is needed. Methods A prospective…”
Get full text

Perioperative mortality and morbidity after sublobar versus lobar resection for early-stage non-small-cell lung cancer: post-hoc analysis of an international, randomised, phase 3 trial (CALGB/Alliance 140503) by Altorki, Nasser K, Wang, Xiaofei, Wigle, Dennis, Gu, Lin, Darling, Gail, Ashrafi, Ahmad S, Landrenau, Rodney, Miller, Daniel, Liberman, Moishe, Jones, David R, Keenan, Robert, Conti, Massimo, Wright, Gavin, Veit, Linda J, Ramalingam, Suresh S, Kamel, Mohamed, Pass, Harvey I, Mitchell, John D, Stinchcombe, Thomas, Vokes, Everett, Kohman, Leslie J

“…Increased detection of small-sized, peripheral, non-small-cell lung cancer has renewed interest in sublobar resection instead of lobectomy, the traditional…”
Get full text

Impact of tumor size on survival in stage IA non-small cell lung cancer: a case for subdividing stage IA disease by Gajra, Ajeet, Newman, Nancy, Gamble, Gary P., Abraham, Naif Z., Kohman, Leslie J., Graziano, Stephen L.

“…Purpose: Stage IA (T1N0M0) non-small cell lung cancer (NSCLC) includes all lesions up to 3 cm in diameter. With the use of advanced imaging techniques, smaller…”
Get full text

Cancer and Leukemia Group B Surgery Committee by Kohman, Leslie J

“…Surgeons play a vital role in the Cancer and Leukemia Group B by providing patients and specimens for studies of the common solid tumors, and more recently, by…”
Get full text

Poor correspondence between clinical and pathologic staging in stage 1 non-small cell lung cancer: results from CALGB 9761, a prospective trial by D’Cunha, Jonathan, Herndon, James E., Herzan, Debra L., Patterson, G. Alexander, Kohman, Leslie J., Harpole, David H., Kernstine, Kemp H., Kern, Jeffrey A., Green, Mark R., Maddaus, Michael A., Kratzke, Robert A.

“…A major problem with the staging system for non-small cell lung cancer (NSCLC) is clinical underestimation of the extent of disease. Many patients with…”
Get full text

Detection of Occult Micrometastases in Patients With Clinical Stage I Non-Small-Cell Lung Cancer: A Prospective Analysis of Mature Results of CALGB 9761 (Alliance) by Martin, Linda W, D'Cunha, Jonathan, Wang, Xiaofei, Herzan, Debra, Gu, Lin, Abraham, Naif, Demmy, Todd L, Detterbeck, Frank C, Groth, Shawn S, Harpole, David H, Krasna, Mark J, Kernstine, Kemp, Kohman, Leslie J, Patterson, G Alexander, Sugarbaker, David J, Vollmer, Robin T, Maddaus, Michael A, Kratzke, Robert A

“…Outcomes after resection of stage I non-small-cell lung cancer (NSCLC) are variable, potentially due to undetected occult micrometastases (OM). Cancer and…”
Get full text

Controversies in the management of malignant thymoma by Kohman, L J

“…The management of most thymomas is relatively straightforward: surgical resection remains the primary mode of therapy. However, the literature contains many…”
Get more information

Global health initiatives in cardiothoracic surgery: ethical considerations and guidelines by Fenton, Kathleen N, Novick, William M, Entwistle, John W, Moffatt-Bruce, Susan D, Sade, Robert M

Get full text

Intraoperative sentinel node mapping with technitium-99 in lung cancer: results of CALGB 140203 multicenter phase II trial by Liptay, Michael J, D'amico, Thomas A, Nwogu, Chumy, Demmy, Todd L, Wang, Xiaofei F, Gu, Lin, Litle, Virginia R, Swanson, Scott J, Kohman, Leslie J

“…Sentinel node mapping with radioactive technetium in non-small cell lung cancer has been shown to be feasible in several single institution reports. The Cancer…”
Get more information

Definitive treatment of poor-risk patients with stage I lung cancer: a single institution experience by Hsie, Michael, Morbidini-Gaffney, Stefania, Kohman, Leslie J, Dexter, Elisabeth, Scalzetti, Ernest M, Bogart, Jeffrey A

“…Lung cancer remains the leading cause of cancer death in both men and women. A substantial number of patients with early stage non-small cell lung cancer…”
Get more information

Limited resection as a cure for early lung cancer: time to challenge the gold standard? by Altorki, Nasser, Kohman, Leslie J, Veit, Linda J, You, Y Nancy, Boughey, Judy C

Get full text

Molecular staging of lung cancer: Real-time polymerase chain reaction estimation of lymph node micrometastatic tumor cell burden in stage I non-small cell lung cancer—preliminary results of cancer and leukemia group B trial 9761 by D'Cunha, Jonathan, Corfits, Angela L., Herndon, James E., Kern, Jeffrey A., Kohman, Leslie J., Patterson, G.Alexander, Kratzke, Robert A., Maddaus, Michael A.

“…Objective: The 5-year survival for patients with surgically resected stage I non-small cell lung cancer is only 60% to 70%, probably because of undetected…”
Get full text

Prognostic Significance of K-ras Codon 12 Mutations in Patients With Resected Stage I and II Non–Small-Cell Lung Cancer by GRAZIANO, S. L, GAMBLE, G. P, NEWMAN, N. B, ABBOTT, L. Z, ROONEY, M, MOOKHERJEE, S, LAMB, M. L, KOHMAN, L. J, POIESZ, B. J

“…The aim of this study was to investigate the prognostic importance of codon 12 K-ras mutations in patients with early-stage non-small-cell lung cancer (NSCLC)…”
Get full text

A Phase III Study of Surgical Resection and Paclitaxel/Carboplatin Chemotherapy with or Without Adjuvant Radiation Therapy for Resected Stage III Non–Small-Cell Lung Cancer: Cancer and Leukemia Group B 9734 by Perry, Michael C, Kohman, Leslie J, Bonner, James A, Gu, Lin, Wang, Xiaofei, Vokes, Everett E, Green, Mark R

“…Abstract Purpose Patients with completely resected stage IIIA (N2) non–small-cell lung cancer (NSCLC) are at substantial risk for locoregional and systemic…”
Get full text

Resection for lung cancer in the elderly patient by Dexter, Elisabeth U, Jahangir, Nauman, Kohman, Leslie J

“…Age is sometimes used as an excuse not to resect lung cancer. Nugent et al [10] noted that, although only 6% of patients younger than 45 years had stage I or…”
Get more information

Mentorship, Women Thoracic Surgeons, and the Thoracic Surgery Foundation for Research and Education by Benfield, John R., Kohman, Leslie J.

Get full text